BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for SUNESIS PHARMACEUTICALS INC CO:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.